Xcout Intel
Duo Oncology Inc. competitors & alternatives
The 12 closest competitors and alternatives to Duo Oncology Inc. among biotechnology companies — ranked by similarity to what Duo Oncology Inc. actually does, not by market-cap band.
Subscribe to see Duo Oncology Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Duo Oncology Inc.
Duo Oncology Inc. is a United States-based company located in Pittsburgh, Pennsylvania, specializing in stroma-penetrating nanomedicine to improve cancer treatments.
Duo Oncology Inc. at a glance
Duo Oncology Inc. is a biotechnology company headquartered in United States. It has raised at least $26M across the 4 funding rounds on record. Its most recent funding round, Seed, raised $1.6M in June 2025. Xcout tracks 16 named people at Duo Oncology Inc., including SAM ROTHSTEIN (President and CEO).
Duo Oncology Inc. leadership
- SAM ROTHSTEINPresident and CEO
- Dr. Sam Rothstein, PhDCEO & Co-Founder
- Dr. Jing-Zhou Hou, MD, PhDCo-Founder
- Dr. Song Li, MD, PhDCo-Founder
- JINGJING SUNPromoter
- JING-ZHOU HOUExecutive Officer
10 more named people on record for Duo Oncology Inc., with roles, board committees and tenure — see the full roster →
Duo Oncology Inc. funding rounds
At least $26M raised across the 4 rounds on record. The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $1.6M | 6 named | |
| Seed | $19M | 6 named | |
| SEC Form D filing | $4.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Duo Oncology Inc. competitors
Ranked by semantic similarity — how close each company is to Duo Oncology Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Western Oncolytics Ltd. is a cutting-edge biotechnology and pharmaceutical company headquartered in Pittsburgh, Pennsylvania, focused on developing novel cancer therapies and drug pipelines.
Life Sciences
MetasTx Inc. is a biotechnology company headquartered in Pittsburgh, Pennsylvania, focused on creating novel therapeutics to treat diseases.
Similar biotechnology company
DeuterOncology is a clinical-stage drug development company that designs and develops deuterated MET kinase inhibitors as targeted therapies for lung cancer and other advanced solid tumors. Its lead product, DO-2, is a selective, brain-penetrant MET kinase inhibitor intended to improve tolerability and reduce toxicity compared to existing treatments.
Similar biotechnology company
Phenomic AI Inc. is a biotechnology company developing novel antibody-based therapies directed against the tumor stroma to improve patient outcomes.
Similar biotechnology company
Dome Therapeutics is a preclinical biotechnology company developing a nanomedicine designed to target brain cancer stem cells that survive standard glioblastoma treatments and drive tumor recurrence. Using a proprietary nanoparticle delivery platform, the company aims to cross the blood-brain barrier to deliver therapeutic payloads directly to these treatment-resistant cells.
Similar biotechnology company
Surface Oncology is a clinical-stage biotechnology company focused on developing immunotherapies that target the tumor microenvironment and enhance anti-tumor immune responses. Its programs are intended for cancer patients and are developed for use by oncology physicians and healthcare systems, with potential pharmaceutical partnerships.
Health & Life Sciences
Matrisome Bio is a biotechnology startup headquartered in Cambridge, Massachusetts, focused on transforming cancer therapy by delivering potent payloads directly to the extracellular matrix of tumors and metastases.
Similar biotechnology company
Undaunted Bio, Inc. is an AI-driven drug repurposing company headquartered in Pittsburgh, United States, focused on treatments for neuropathic pain.
Similar biotechnology company
Red Ace Bio is a biotechnology company founded in 2023 to develop next-generation gene therapies targeting lasting cancer remission. The company is headquartered in State College, Pennsylvania.
Similar biotechnology company
OncoRock Therapeutics Inc. is a corporation located in Little Rock, Arkansas. The company operates in the life sciences sector, focusing on the research and development of oncology therapeutics.
Similar biotechnology company
Xanadu Bio, Inc. is a biotechnology company that develops next-generation polymer nanoparticle delivery platforms for mRNA and other nucleic acid-based therapies. Utilizing its proprietary poly(amine-co-ester) (PACE) polymer technology, the company creates tunable, organ-specific treatments for oncology and immunology, as well as intranasal vaccines for viral respiratory pathogens.
Similar biotechnology company
Starton Therapeutics is a clinical-stage biotechnology company that develops proprietary continuous delivery technology systems to improve standard-of-care cancer therapies. The company utilizes subcutaneous, oral, and transdermal delivery platforms to transform FDA-approved active ingredients for superior patient outcomes.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Duo Oncology Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Duo Oncology Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →